Management Consulting

Corporate Strategy Planning

Aligning your business with your goals

When you partner with Alira Health, we’ll deliver full spectrum support from our team of global specialists. You’ll benefit from a comprehensive industry evaluation, complete with local market condition assessment. Together, we’ll review your company operations and create a short- and long-term plan to align them with your mission, values, goals and vision.

Creating a tailored, focused plan for the future

The complex nature of the healthcare and life sciences landscape demands intentional long-range planning. The attrition and costs of the industry favor companies who dedicate resources to creating strategies that provide detailed operational activities to meet their long-term goals.
That's why, as your partner, Alira Health creates a plan tailored for your business with four objectives in mind:
  • Formalizing your business vision and long-term ambition
  • Outline the full spectrum of scenarios that may take place
  • Define a set of assumptions and review the impact of changes
  • Align employees around the company’s long-term ambition, defining operational activities and KPIs to support the goals

Why choose Alira Health?

As your partner, Alira Health supports your innovation, optimizing product development success every step of the way. Our integrated, collaborative teams provide a lifecycle approach to delivering our services, including:

  • Regulatory strategy
  • Regulatory intelligence
  • Regulatory operations
  • Clinical
  • Market access
  • Click here to see how we delivered a recent growth opportunity assessment for a leading pharmaceutical company

Related news

Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
Pharma
News December 15, 2020
Welcome Daniela Sica, Vice President, Business Development, Pharma and Biotech
We are pleased to announce that Daniela Sica has joined the firm as Vice President, Business Development, Pharma and Biotech.
Market Access Pharma
Publications November 2, 2020
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)
Advanced Analytics Market Access Pharma
Publications November 1, 2020
Our Parallel Trade Expertise
Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.